Related Experiment Video
Updated: Jun 22, 2026
Microglia as a Surrogate Biosensor to Determine Nanoparticle Neurotoxicity
Published on: October 25, 2016
The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments
Anja Henn1, Søren Lund, Maj Hedtjärn
1University of Konstanz, Konstanz, Germany. anja.henn@uni-konstanz.de
Abstract:
The role of microglia in neurodegeneration, toxicology and immunity is an expanding area of biomedical research requiring large numbers of animals. Use of a microglia-like cell line would accelerate many research programmes and reduce the necessity of continuous cell preparations and animal experimentation, provided that the cell line reproduces the in vivo situation or primary microglia (PM) with high fidelity. The immortalised murine microglial cell line BV-2 has been used frequently as a substitute for PM, but recently doubts were raised as to their suitability. Here, we re-evaluated strengths and potential short-comings of BV-2 cells. Their response to lipopolysaccharide was compared with the response of microglia in vitro and in vivo. Transcriptome (480 genes) and proteome analyses after stimulation with lipopolysaccharide indicated a reaction pattern of BV-2 with many similarities to that of PM, although the average upregulation of genes was less pronounced. The cells showed a normal regulation of NO production and a functional response to IFN-gamma, important parameters for appropriate interaction with T cells and neurons. BV-2 were also able to stimulate other glial cells. They triggered the translocation of NF-kappaB, and a subsequent production of IL-6 in astrocytes. Thus, BV-2 cells appear to be a valid substitute for PM in many experimental settings, incuding complex cell-cell interaction studies.
Insights
The BV-2 cell line, a microglia substitute, closely mimics primary microglia responses to lipopolysaccharide. BV-2 cells are suitable for research, including complex cell-cell interactions, reducing animal use.
Area of Science:
- Neuroscience
- Immunology
- Toxicology
Background:
- Microglia are crucial in neurodegeneration, toxicology, and immunity, necessitating extensive animal research.
- The BV-2 cell line is a common substitute for primary microglia (PM), but its validity has been questioned.
Purpose of the Study:
- To re-evaluate the strengths and limitations of the BV-2 microglial cell line.
- To compare BV-2 cell responses to lipopolysaccharide (LPS) with primary microglia (PM) in vitro and in vivo.
Main Methods:
- Transcriptome (480 genes) and proteome analyses of BV-2 cells stimulated with LPS.
- Assessment of nitric oxide (NO) production and interferon-gamma (IFN-γ) response in BV-2 cells.
- Evaluation of BV-2 cell-induced activation of astrocytes, including NF-κB translocation and IL-6 production.
Main Results:
- BV-2 cells exhibited a reaction pattern similar to PM upon LPS stimulation, with comparable gene upregulation.
- Normal regulation of NO production and functional response to IFN-γ were observed in BV-2 cells.
- BV-2 cells successfully stimulated astrocytes, inducing NF-κB translocation and IL-6 production.
Conclusions:
- BV-2 cells demonstrate significant similarities to primary microglia (PM) in response to LPS.
- BV-2 cells maintain essential functions like NO production and IFN-γ responsiveness.
- The BV-2 cell line is a valid and valuable substitute for PM in various research settings, including studies of glial cell interactions.
